Navigation

morrhuate sodium (Scleromate)

 

Classes: Sclerosing Agents

Dosing and uses of Scleromate (morrhuate sodium)

 

Adult dosage forms and strengths

injectable solution

  • 50mg/mL

 

Obliteration of Varicose Veins

May use test dose of 0.25-1 mL of 5% solution

Small/medium Veins: 50-100 mg IV

Large Veins: 150-250 mg IV

May repeat q5-7Days

 

Pediatric dosage forms and strengths

N/A

 

Scleromate (morrhuate sodium) adverse (side) effects

Frequency not defined

Drowsiness

Headache

Burning or cramping sensations

Pulmonary embolism

Anaphylactic reactions

Injection site reactions

 

Warnings

Contraindications

Persistent deep vein occlusion

Valvular incompetence

Acute superficial thrombophlebitis; underlying arterial disease

Varicosities caused by abdominal & pelvic tumors

Uncontrolled DM, thyrotoxicosis, TB, neoplasms, asthma, sepsis, blood dyscrasias, acute respiratory or skin disease

Bedridden patients

 

Cautions

Delay in patients with acute local or systemic infections

Extensive therapy inadvisable in severely debilitated/senile patients

Extravasation may cause tissue necrosis

 

Pregnancy and lactation

Pregnancy category: N/A (no info)

Lactation: N/A

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Scleromate (morrhuate sodium)

Mechanism of action

Sclerosing agent, causes inflammation of vascular intimal layer and consequent thrombus formation

 

Administration

IV Administration

May use a test dose (0.25-1 mL) first to determine sensitivity

If solid matter present, warm ampule by immersing in hot water until clear

Because injection froths easily, a large bore needle should be used to fill syringe

Use smaller bore needle for injection

May give dose as single or multiple injections

 

Storage

Store at 15-30°C

Do not expose to air

Do not freeze